Published in Hepatitis Weekly, March 4th, 2002
"We conducted a prospective, controlled, multicenter trial to assess if earlier changes of serum hepatitis C virus (HCV) RNA levels were predictable for long-term effect, and if a short-term therapy was effective in such patients," S. Kakumu and coauthors said in the February 2002 issue of Hepatology Research.
Their findings suggested that testing for viral markers early in the treatment process could provide important information...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly